Anquan Shang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anquan Shang has a total of 376 co-authors. Here are the top co-authors by number of shared publications:
- Weiwei Wang
Department of Pathology
22 shared publications - Dong Li
Department of Laboratory Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
19 shared publications Weiwei Wang
Department of Laboratory Medicine, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang, China
19 shared publicationsJunlu Wu
Department of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, P.R. China
16 shared publicationsWenying Lu
Department of Laboratory Medicine, Tinghu People’s Hospital, Yancheng, People’s Republic of China
12 shared publicationsPing Ji
Department of Clinical Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
11 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Elsevier in Cancer Bioscience
Splenic Extramedullary Granulopoiesis and Neutrophil States in Cancer Immunity: Systemic Immunosuppression and Therapeutic Resistance
- 7 September 2026
- Published by Elsevier in Cancer Bioscience
Open AccessSplenic Extramedullary Granulopoiesis and Neutrophil States in Cancer Immunity: Systemic Immunosuppression and Therapeutic Resistance
- Open Access
The Prediction of Extended Hospital Length of Stay in Patients After Endoscopic Endonasal Transsphenoidal Surgery for the Resection of Non-Functioning Pituitary Adenomas: A Dual-Center Retrospective Analysis
Background: Prolonged hospitalization after endoscopic endonasal transsphenoidal surgery for non-functioning pituitary adenomas increases costs and complications. Early identification of high-risk patients is crucial for optimizing perioperative management. Methods: In this dual-center retrospective study of 368 patients, a predictive model was developed using a training cohort (n = 268). Prolonged length of stay was defined as ≥75th percentile (≥16 days). LASSO regression selected features from clinical, radiological, and perioperative variables. Independent predictors from multivariable logistic regression were dichotomized via ROC analysis and integrated into a nomogram. Model performance was assessed internally and validated externally (n = 100). Results: Six independent predictors were identified: age > 50 years, vertical tumor diameter > 17.8 mm, anteroposterior diameter > 20.5 mm, transverse diameter > 17.8 mm, anesthesia duration > 194 min, and systolic blood pressure > 119 mmHg. The nomogram showed moderate but reproducible discrimination (AUC = 0.762 in training; 0.750 in validation). Calibration and decision curve analysis confirmed good fit and clinical utility. Conclusion: We developed and validated a practical nomogram predicting prolonged hospitalization risk using readily available perioperative variables. This tool may assist individualized risk stratification and perioperative planning in comparable clinical settings, with potential implications for patient flow and resource utilization.
Open AccessThe Prediction of Extended Hospital Length of Stay in Patients After Endoscopic Endonasal Transsphenoidal Surgery for the Resection of Non-Functioning Pituitary Adenomas: A Dual-Center Retrospective Analysis
Background: Prolonged hospitalization after endoscopic endonasal transsphenoidal surgery for non-functioning pituitary adenomas increases costs and complications. Early identification of high-risk patients is crucial for optimizing perioperative management. Methods: In this dual-center retrospective study of 368 patients, a predictive model was developed using a training cohort (n = 268). Prolonged length of stay was defined as ≥75th percentile (≥16 days). LASSO regression selected features from clinical, radiological, and perioperative variables. Independent predictors from multivariable logistic regression were dichotomized via ROC analysis and integrated into a nomogram. Model performance was assessed internally and validated externally (n = 100). Results: Six independent predictors were identified: age > 50 years, vertical tumor diameter > 17.8 mm, anteroposterior diameter > 20.5 mm, transverse diameter > 17.8 mm, anesthesia duration > 194 min, and systolic blood pressure > 119 mmHg. The nomogram showed moderate but reproducible discrimination (AUC = 0.762 in training; 0.750 in validation). Calibration and decision curve analysis confirmed good fit and clinical utility. Conclusion: We developed and validated a practical nomogram predicting prolonged hospitalization risk using readily available perioperative variables. This tool may assist individualized risk stratification and perioperative planning in comparable clinical settings, with potential implications for patient flow and resource utilization.
- Open Access
- 17 April 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Development of a clinically applicable prediction tool for lymph node metastasis in papillary thyroid carcinoma using lasso-logistic regression
This study aims to analyze clinical and laboratory data from patients to identify indicators associated with lymph node metastasis (LNM) in papillary thyro
- 17 April 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessDevelopment of a clinically applicable prediction tool for lymph node metastasis in papillary thyroid carcinoma using lasso-logistic regression
This study aims to analyze clinical and laboratory data from patients to identify indicators associated with lymph node metastasis (LNM) in papillary thyro
- Open Access
- 5 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Colorectal cancer-derived extracellular vesicles: at the crossroads of the tumor microenvironment and gut microbiota
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. The clinical treatment faces multiple challenges of significant tumor heterogeneity, prevalence of chemo-resistance, low response rate to immunotherapy, and the impact of the patient’s intestinal microenvironment. Recent studies have shown that extracellular vesicles (EVs), as important information transfer carriers for regulating tumorigenesis and development, play a key role in mediating the complex regulatory network of the gut microbiota-tumor microenvironment (TME). Based on current research advances, our review systematically elucidates how CRC-derived EVs function as dynamic molecular messengers, mediating bidirectional interactions between the TME and the gut microbiota. It also provides a comprehensive outline of EV biogenesis and the key signaling pathways regulated by their diverse molecular cargo. It further delineates how these pathways act in concert to promote the formation of an immunosuppressive microenvironment, drive tumor metastasis, and confer therapy resistance. This review aims to provide a coherent theoretical framework for understanding CRC progression and drug resistance, to offer a scientific rationale for novel therapies targeting CRC-derived EVs, and to highlight future research directions essential for overcoming methodological bottlenecks, deciphering complex interaction networks, and advancing clinical translation.
- 5 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17
Open AccessColorectal cancer-derived extracellular vesicles: at the crossroads of the tumor microenvironment and gut microbiota
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. The clinical treatment faces multiple challenges of significant tumor heterogeneity, prevalence of chemo-resistance, low response rate to immunotherapy, and the impact of the patient’s intestinal microenvironment. Recent studies have shown that extracellular vesicles (EVs), as important information transfer carriers for regulating tumorigenesis and development, play a key role in mediating the complex regulatory network of the gut microbiota-tumor microenvironment (TME). Based on current research advances, our review systematically elucidates how CRC-derived EVs function as dynamic molecular messengers, mediating bidirectional interactions between the TME and the gut microbiota. It also provides a comprehensive outline of EV biogenesis and the key signaling pathways regulated by their diverse molecular cargo. It further delineates how these pathways act in concert to promote the formation of an immunosuppressive microenvironment, drive tumor metastasis, and confer therapy resistance. This review aims to provide a coherent theoretical framework for understanding CRC progression and drug resistance, to offer a scientific rationale for novel therapies targeting CRC-derived EVs, and to highlight future research directions essential for overcoming methodological bottlenecks, deciphering complex interaction networks, and advancing clinical translation.
- Top Cited PapersOpen Access
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1736384
Biofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications
Microbial biofilms are increasingly recognized as critical modulators of chronic airway inflammation and immune dysregulation in pulmonary diseases. This review summarizes current evidence on how biofilm formation and persistence alter host immune responses, contributing to the pathogenesis of chronic lung disorders. We first outline the characteristics of respiratory biofilms and the major pathogens involved. We then discuss how biofilms reshape innate and adaptive immunity—impairing pattern recognition receptor signaling, promoting neutrophil extracellular trap (NET) formation, altering macrophage polarization, and skewing T-cell differentiation. These immune alterations sustain low-grade inflammation, tissue remodeling, and immune tolerance, driving disease progression in chronic obstructive pulmonary disease, bronchiectasis, severe asthma, and even lung cancer. We further highlight emerging diagnostic biomarkers and therapeutic approaches targeting biofilm-associated immune pathways, including combined antibiofilm and immunomodulatory strategies. Finally, we identify key knowledge gaps and propose future research directions, emphasizing multi-omics approaches and personalized interventions to better define and target biofilm-driven immune dysregulation in chronic respiratory diseases.
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1736384
Top Cited PapersOpen AccessBiofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications
Microbial biofilms are increasingly recognized as critical modulators of chronic airway inflammation and immune dysregulation in pulmonary diseases. This review summarizes current evidence on how biofilm formation and persistence alter host immune responses, contributing to the pathogenesis of chronic lung disorders. We first outline the characteristics of respiratory biofilms and the major pathogens involved. We then discuss how biofilms reshape innate and adaptive immunity—impairing pattern recognition receptor signaling, promoting neutrophil extracellular trap (NET) formation, altering macrophage polarization, and skewing T-cell differentiation. These immune alterations sustain low-grade inflammation, tissue remodeling, and immune tolerance, driving disease progression in chronic obstructive pulmonary disease, bronchiectasis, severe asthma, and even lung cancer. We further highlight emerging diagnostic biomarkers and therapeutic approaches targeting biofilm-associated immune pathways, including combined antibiofilm and immunomodulatory strategies. Finally, we identify key knowledge gaps and propose future research directions, emphasizing multi-omics approaches and personalized interventions to better define and target biofilm-driven immune dysregulation in chronic respiratory diseases.
- Open Access
- 10 January 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Multimodal intelligent prediction model for in vitro fertilization
Artificial intelligence has facilitated the automated selection of embryos and the prediction of pregnancy outcomes during in vitro fertilization (IVF), yet multimodal approaches remain underexplored–particularly for predicting multiple specific outcomes such as singleton pregnancy vs. multiple pregnancy, and miscarriage vs. live birth. In this study, we propose VaTEP (Video and Table model for Embryo Prediction), a multimodal embryo prediction model integrating time-lapse system (TLS) videos and tabular clinical variables. VaTEP is first pretrained on two pre-tasks (TLS video reconstruction and embryo developmental phase prediction) to fully capture the rich spatiotemporal dynamics and developmental information contained in the video, and further improved by a multiple frame sampling strategy and multitask learning framework. These designs enable VaTEP to estimate the probabilities of fetal heartbeat, singleton vs. multiple pregnancy, and miscarriage vs. live birth, promoting more informed embryo selection and outcome precognition. This helps reduce the risk of implantation failure by minimizing the chances of non-viable pregnancies, multiple gestations, and miscarriages. VaTEP offers a comprehensive and data-driven tool for personalized IVF decision-making, supporting safer and more effective reproductive treatment.
- 10 January 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessMultimodal intelligent prediction model for in vitro fertilization
Artificial intelligence has facilitated the automated selection of embryos and the prediction of pregnancy outcomes during in vitro fertilization (IVF), yet multimodal approaches remain underexplored–particularly for predicting multiple specific outcomes such as singleton pregnancy vs. multiple pregnancy, and miscarriage vs. live birth. In this study, we propose VaTEP (Video and Table model for Embryo Prediction), a multimodal embryo prediction model integrating time-lapse system (TLS) videos and tabular clinical variables. VaTEP is first pretrained on two pre-tasks (TLS video reconstruction and embryo developmental phase prediction) to fully capture the rich spatiotemporal dynamics and developmental information contained in the video, and further improved by a multiple frame sampling strategy and multitask learning framework. These designs enable VaTEP to estimate the probabilities of fetal heartbeat, singleton vs. multiple pregnancy, and miscarriage vs. live birth, promoting more informed embryo selection and outcome precognition. This helps reduce the risk of implantation failure by minimizing the chances of non-viable pregnancies, multiple gestations, and miscarriages. VaTEP offers a comprehensive and data-driven tool for personalized IVF decision-making, supporting safer and more effective reproductive treatment.
- 2 January 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (2) , 1059-1076
HSP72-AMPK axis mitigates hypoxia-induced cellular senescence to promote colorectal cancer development
- 2 January 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (2) , 1059-1076
HSP72-AMPK axis mitigates hypoxia-induced cellular senescence to promote colorectal cancer development
- Open Access
- 26 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives
Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with non-small cell lung cancer (NSCLC), yet their efficacy is hindered by the immu
- 26 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessLong non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives
Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with non-small cell lung cancer (NSCLC), yet their efficacy is hindered by the immu
- Open Access
- 23 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Long non-coding RNAs in osteosarcoma: multifaceted regulators of malignancy and therapeutic resistance
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, with an annual incidence of approximately 3–4 cases pe
- 23 December 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessLong non-coding RNAs in osteosarcoma: multifaceted regulators of malignancy and therapeutic resistance
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, with an annual incidence of approximately 3–4 cases pe
- 17 December 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 83 (4) , E121-E122
Letter to the Editor: Competing risk and surveillance thresholds for HCC in patients with PSC
- 17 December 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 83 (4) , E121-E122
Letter to the Editor: Competing risk and surveillance thresholds for HCC in patients with PSC